http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007070517-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5ec115412f48014440e75cceb4efb2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62f142a848ca6bacf45804f1409f3a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c727d0aef5b1f28290f7ccdf941d6ead
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7918c65cbf7ab3fed492240d46922ba3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f9991d87c67c19e41d59ab56efd894b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb182437a6753dc833ae2c5c38a14a59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a62404e8ea2d722fb6984f57296431b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93f4235c6214991a35759d6119483744
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 2006-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_686b6922be457f1f36de0363f7547aa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ab7ce247b27bead557d1d2ddd87cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ee72ea7a161fccc452474ad4c42b8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c790944f685035e90f4c195e1cbe6330
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78f6ab8480d32ddca6080c0849359864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92eb96c06c7d370e27966e356df72cd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d006bdae7fea1cd4a0094fe2fc3efb
publicationDate 2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007070517-A3
titleOfInvention Fexofenadine suspension formulation
abstract The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.
priorityDate 2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066974-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03041683-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129192935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129511773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6603853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11435488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135833367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129629301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127422759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129015737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9870655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11217587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128470051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129790931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129192932

Total number of triples: 52.